IP Library Granted Patent US 8,524,204
Granted Patent B2
US 8,524,204 · App. 13/298,985 · Granted Sep 3, 2013

Cosmetic compositions and methods for inhibiting or reducing trypsin activity

Inventors: Tomohiro Hakozaki (Cincinnati, OH); Leo Timothy Laughlin, II (Mason, OH)
Assignee: The Procter & Gamble Company
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,524,204
App. No.
13/298,985
Granted
Sep 3, 2013
Kind
B2
Abstract

A cosmetic composition formulated for topical application to skin is provided. The composition includes a safe and effective amount of cyclohexane-1,2,3,4,5,6-hexol; a safe and effective amount of an N-acyl amino acid compound; and a dermatologically acceptable vehicle.

Claims (21)

1. A cosmetic composition formulated for topical application to skin, comprising:

a safe and effective amount of cyclohexane-1,2,3,4,5,6-hexol;

a safe and effective amount of an N-acyl amino acid compound; and

a dermatologically acceptable vehicle, wherein the ratio of N-acyl amino acid compounds to cyclohexane-1,2,3,4,5,6-hexol compounds in the cosmetic combination is between about 1:100 and about 10:1.

2. The cosmetic composition of claim 1 , wherein the concentration of cyclohexane-1,2,3,4,5,6-hexol is between about 2% and 3% by weight of the cosmetic composition.

3. The cosmetic composition of claim 1 , wherein the N-acyl amino acid compound is undecylenoyl phenylalanine and the concentration of undecylenoyl phenylalanine is between about 0.2% and about 1% by weight of the cosmetic composition.

4. The cosmetic composition of claim 1 , further comprising a vitamin B3 compound.

5. The cosmetic composition of claim 4 , wherein the concentration of the vitamin B3 compound is between about 3% and about 5% by weight of the cosmetic composition.

6. The cosmetic composition of claim 4 , wherein the vitamin B3 compound is niacinamide.

7. The cosmetic composition of claim 1 , further comprising 2-hexyldecan-1-ol.

8. The cosmetic composition of claim 7 , wherein the concentration of 2-hexyldecan-1-ol is between about 2.5% and about 5% by weight of the cosmetic composition.

9. A cosmetic composition formulated for topical application to skin, comprising:

a safe and effective amount of cyclohexane-1,2,3,4,5,6-hexol;

a safe and effective amount of an N-acyl amino acid compound;

a safe and effective amount of a vitamin B3 compound;

a safe and effective amount of 2-hexyldecan-1-ol; and

a dermatologically acceptable vehicle, wherein the ratio of N-acyl amino acid compounds to cyclohexane-1,2,3,4,5,6-hexol compounds in the cosmetic combination is between about 1:100 and about 10:1.

10. The cosmetic composition of claim 9 , wherein the N-acyl amino acid compound is undecylenoyl phenylalanine and the concentration of undecylenoyl phenylalanine is between about 0.2% and about 1% by weight of the cosmetic composition.

11. The cosmetic composition of claim 9 , wherein the concentration of cyclohexane-1,2,3,4,5,6-hexol is between about 2% and about 3% by weight of the cosmetic composition.

12. The cosmetic composition of claim 9 , wherein the concentration of the vitamin B3 compound is between about 3% and about 5% by weight of the cosmetic composition.

13. The cosmetic composition of claim 9 , wherein the concentration of 2-hexyldecan-1-ol is between about 2.5% and about 5% by weight of the cosmetic composition.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2012
From: HAKOZAKI, TOMOHIRO; LAUGHLIN, LEO TIMOTHY, II
To: THE PROCTER & GAMBLE COMPANY
Reel/Frame 027714/0525 →
Continuity (2)
Provisional Application 61415632 · Nov 19, 2010
Related Publication 20120148515A1 · Jun 14, 2012